| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 25.811 | 41.986 | 106.935 | 179.169 |
| Total Income - EUR | - | - | - | - | - | - | 25.811 | 41.986 | 108.802 | 189.041 |
| Total Expenses - EUR | - | - | - | - | - | - | 3.834 | 19.187 | 79.571 | 129.842 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 21.977 | 22.799 | 29.231 | 59.198 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 21.202 | 21.539 | 28.447 | 54.467 |
| Employees | - | - | - | - | - | - | 0 | 1 | 2 | 3 |
Check the financial reports for the company - Dr. Bontaş Silviu S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 599 | 1.898 | 112.760 | 92.793 |
| Current Assets | - | - | - | - | - | - | 20.845 | 23.012 | 31.507 | 41.810 |
| Inventories | - | - | - | - | - | - | 0 | 95 | 6.219 | 0 |
| Receivables | - | - | - | - | - | - | 0 | 19.227 | 1.718 | 1.952 |
| Cash | - | - | - | - | - | - | 20.845 | 3.690 | 23.570 | 39.857 |
| Shareholders Funds | - | - | - | - | - | - | 21.243 | 21.589 | 30.967 | 64.371 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 201 | 3.322 | 71.505 | 38.427 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 41.794 | 31.804 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Dr. Bontaş Silviu S.r.l.